U.S. Markets closed

PTC Therapeutics: 3Q Earnings Snapshot

SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Tuesday reported a loss of $60 million in its third quarter.

The South Plainfield, New Jersey-based company said it had a loss of $1.06 per share. Losses, adjusted for non-recurring costs, came to 89 cents per share.

The biopharmaceutical company posted revenue of $71.4 million in the period.

PTC Therapeutics shares have increased 15% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $39.31, an increase of slightly more than 8% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT